Analysts Set Synopsys, Inc. (NASDAQ:SNPS) PT at $562.13

Shares of Synopsys, Inc. (NASDAQ:SNPS) have been assigned an average recommendation of “Moderate Buy” from the eighteen analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and eleven have given a buy recommendation to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $562.1333.

Several equities analysts have recently weighed in on the stock. Morgan Stanley increased their target price on Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. JPMorgan Chase & Co. increased their price objective on Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Piper Sandler cut their target price on Synopsys from $630.00 to $602.00 and set an “overweight” rating for the company in a research note on Thursday, December 11th. Robert W. Baird reiterated a “neutral” rating and set a $535.00 price target (down from $670.00) on shares of Synopsys in a research report on Wednesday, September 10th. Finally, Wells Fargo & Company raised their price objective on shares of Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a research report on Thursday, December 11th.

Key Stores Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
• Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
• Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
• Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice

Synopsys Stock Up 0.3%

SNPS opened at $477.14 on Wednesday. The stock has a market cap of $91.29 billion, a PE ratio of 59.72, a price-to-earnings-growth ratio of 3.96 and a beta of 1.16. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. The stock’s fifty day simple moving average is $437.58 and its 200 day simple moving average is $503.61. Synopsys has a 1-year low of $365.74 and a 1-year high of $651.73.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The company had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.Synopsys’s revenue was up 37.8% on a year-over-year basis. During the same quarter last year, the business earned $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, research analysts expect that Synopsys will post 10.64 earnings per share for the current year.

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.62% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Synopsys

Several institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. grew its holdings in shares of Synopsys by 20.7% during the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock worth $8,970,415,000 after acquiring an additional 3,120,401 shares during the period. Victory Capital Management Inc. boosted its position in shares of Synopsys by 238.8% during the third quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock valued at $1,393,506,000 after purchasing an additional 1,990,608 shares in the last quarter. Coatue Management LLC purchased a new stake in Synopsys in the third quarter worth $892,605,000. Capital Research Global Investors raised its holdings in Synopsys by 226.6% in the third quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock worth $1,245,533,000 after purchasing an additional 1,751,432 shares in the last quarter. Finally, State Street Corp raised its holdings in Synopsys by 20.6% in the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock worth $4,322,273,000 after purchasing an additional 1,493,912 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.